BozzaliMCercignaniMSormaniMP: Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. Am J Neuroradiol23 (6): 985–8, 2002.
2.
ChenYAnHZhuH: White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. NeuroImage47: 1154–1162, 2009.
3.
FilippiCGUlugAMRyanE: Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. Am J Neuroradiol22: 277–283, 2001.
4.
GeYLawMHerbertJ: Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. Am J Neuroradiol Oct; 26 (9): 2316–9, 2005.
5.
GuoACJewellsVLProvenzaleJM: Analysis of normal-appearing white matter in multiple sclerosis: Comparison of diffusion tensor MR imaging and magnetization transfer imaging. Am J Neuroradiol22 (10): 1893–900, 2001.
6.
GuoACMacFallJRProvenzaleJM: Multiple sclerosis: Diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology222 (3): 729–36, 2002.
7.
HaackeEMMakkiMGeY. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. Mar; 29 (3): 537–44, 2009.
8.
KavanaghECHeranMKSFentonDM: Diffusion-weighted imaging findings in Balo concentric sclerosis. The British Journal of Radiology79: e28–e31, 2006.
9.
LarssonHBThomsenCFrederiksenJ: In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging10 (1): 7–12, 1992.
MalhotraHSJainKKAgarwalA: Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Mult Scler15: 193, 2009.
12.
NusbaumAO: Diffusion tensor MR imaging of gray matter in different multiple sclerosis phenotypes. Am J Neuroradiol23 (6): 899–900, 2002.
13.
RaginABStoreyPCohenBA: Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. Am J Neuroradiol25: 195–200, 2004.
14.
RaginABWuYStoreyP: Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol11: 292–298, 2005.
15.
RossiA: Imaging in acute disseminated encephalomyelitis. Neuroimag Clin N Am1, 8: 149–161, 2008.
16.
SeewannAEnzingerCFilippiM: MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain. J Neurol255: 1–10, 2008.
ThomasBSomasundaramSThamburajK: Clinical applications of susceptibility weighted MR imaging of the brain - a pictorial review. Neuroradiology, Feb; 50 (2): 105–16, 2008.
19.
ThurnherMMCastilloMStadlerA: Diffusion-tensor MR imaging of the brain in human immunodeficiency virus positive patients. Am J Neuroradiol26: 2275–2281, 2005.
20.
ThurnherMMPostMJRiegerA: Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. Am J Neuroradiol May; 22 (5): 977–84, 2001.
21.
WatersPVincentA: Detection of Anti-Aquaporin-4 Antibodies in Neuromyelitis Optica: Current Status of the Assays. The International MS Journal15: 99–105, 2008.
22.
WelshRCRahbarHFoersterB: Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurological symptoms. J Magn Reson Imaging Sep; 26 (3): 541–51, 2007.
23.
WingerchukDMLennonVALucchinettiCF: The spectrum of neuromyelitis optica. Lancet Neurol6: 805–15, 2007.
24.
ZhangL: Diffusion changes in patients with systemic erythematosus. Magn Reson Imag25: 399–405, 2007.
